Evaluation of concurrent chemoradiotherapy for locally advanced NSCLC according to EGFR mutation status

Concurrent chemoradiotherapy (cCRT) is the standard treatment for patients with locally advanced non-small cell lung cancer (LA-NSCLC). However, the efficacy and safety of this treatment has not been compared between patients who possess epidermal growth factor receptor (EGFR) mutations and patients...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncol Lett
Hlavní autoři: Ishihara, Mikiko, Igawa, Satoshi, Sasaki, Jiichiro, Otani, Sakiko, Fukui, Tomoya, Ryuge, Shinichiro, Katono, Ken, Hiyoshi, Yasuhiro, Kasajima, Masashi, Mitsufuji, Hisashi, Kubota, Masaru, Yokoba, Masanori, Katagiri, Masato, Sekiguchi, Akane, Soda, Itaru, Ishiyama, Hiromichi, Hayakawa, Kazushige, Masuda, Noriyuki
Médium: Artigo
Jazyk:Inglês
Vydáno: D.A. Spandidos 2017
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5494758/
https://ncbi.nlm.nih.gov/pubmed/28693247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6231
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky